Your browser doesn't support javascript.
loading
Decreased FOXF1 promotes hepatocellular carcinoma tumorigenesis, invasion, and stemness and is associated with poor clinical outcome.
Zhao, Zhen-Guo; Wang, De-Qiang; Hu, De-Fei; Li, You-Sheng; Liu, Shuang-Hai.
Afiliação
  • Zhao ZG; Department of Surgery, Jinling Hospital, Nanjing Medical University, Nanjing, People's Republic of China; Department of General Surgery, The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, People's Republic of China.
  • Wang DQ; Tumor Treatment Center, The Affiliated Hospital of Jiangsu University, Zhenjiang, People's Republic of China.
  • Hu DF; Clinical Laboratory, The Second People's Hospital of Huai'an, Huai'an, People's Republic of China.
  • Li YS; Department of Surgery, Jinling Hospital, Nanjing Medical University, Nanjing, People's Republic of China.
  • Liu SH; Department of General Surgery, The Affiliated Jiangyin Hospital of Southeast University Medical College, Jiangyin, People's Republic of China.
Onco Targets Ther ; 9: 1743-52, 2016.
Article em En | MEDLINE | ID: mdl-27042124
ABSTRACT
Forkhead box F1 (FOXF1), a member of the forkhead transcription factor superfamily, plays critical roles in the progression of certain types of cancers. However, the expression and function of FOXF1 in human hepatocellular carcinoma (HCC) are still unclear. Quantitative real-time reverse transcription polymerase chain reaction, Western blotting, and immunohistochemistry detected the relatively lower expression status of FOXF1 in HCC cases. Soft agar and transwell assays clearly demonstrated that FOXF1-knockdown cells showed significantly increased in vitro cell tumorigenesis and invasion, and FOXF1-overexpressing cells had significantly reduced growth and invasion potential. Our study also examined the role of FOXF1 in HCC cell stemness by sphere formation, aldehyde dehydrogenase (ALDH1) activity, and CD44/133-positive cell analysis. Enforced FOXF1 expression decreased HCC cell stemness, and the downregulation of FOXF1 promoted cancer cell stemness. The in vivo study showed that overexpressed FOXF1 inhibits nude mouse tumorigenicity with downregulation of CD44 and proliferating cell nuclear antigen. More importantly, loss of FOXF1 expression was linked to poor overall survival time by Kaplan-Meier analysis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article